Find a therapist near you

City or Zip Code:

Powered by: Psychology Today

Advertisement

Related Programs

Once-Daily Medicines for HIV Disease Lipodystrophy in HIV Disease HIV and Anemia: One Patient's Story Coping With HIV Drugs: A Personal Story Making The Decision To Start HIV Therapy

HIV and AIDS

HIV Therapy: What is HAART?

Summary & Participants

When people with HIV have good access to health care, they can expect to live long and well. That's because doctors have learned to combine drugs into regimens that successfully attack the virus at multiple places in its life cycle.

Medically Reviewed On: May 07, 2008

Webcast Transcript

ANNOUNCER: Doctors use drugs against HIV in carefully-planned combinations, known as HAART, or Highly Active Anti-Retroviral Therapy.

KATHLEEN SQUIRES, MD: We now have over 15 antiretroviral medications that are available to us. And the concept behind putting medications together is to try and shut down multiple steps in the life cycle of this virus.

ANNOUNCER: None of these drugs were available during the earliest years of the AIDS epidemic.

KATHLEEN SQUIRES, MD: The first cases of HIV infection were described in 1981 and it wasn't really until the second half of the 80s that we identified agents that were active against HIV.

ANDREW CARR, MD: The first HIV drug was AZT. AZT is a drug that stops the virus inserting itself into the genetic machinery of a human cell.

PETER REISS, MD: It's called a nucleoside analog reverse transcriptase inhibitor, or NRTI, abbreviated... It inhibits reverse transcriptase, and reverse transcriptase is an enzyme, is a protein which is in the virus particle, in the virus, which will translate RNA which is the genetic material that HIV carries in it, into DNA.

ANNOUNCER: When AZT blocks the action of the reverse transcriptase, it prevents the HIV from inserting its genetic material into the human cell, usually certain white blood cells called T cells.

PETER REISS, MD: And what was found out -- what was discovered is that particularly in patients who were already advanced, patients with AIDS, with established AIDS, is to some extent you could prevent new complications.

But, after a while it also became clear that the effect was transient.

ANNOUNCER: Over the course of several years, researchers developed other drugs like AZT.

Then, in the mid 1990s, another class of drugs became available, called Non-Nucleoside Reverse Transcriptase Inhibitors.

They, too, prevent the incorporation of viral genetic material into the host cell.

Also in the mid 1990s came the discovery of drugs called Protease Inhibitors, that work at a different point in the HIV replication cycle.

PETER REISS, MD: Protease inhibitors is different because they target a different viral enzyme which acts a later stage of the life cycle and importantly acts after this integration of DNA into the host genetic material.

ANDREW CARR, MD: Protease drugs don't stop the virus getting into your cells at all. What they do is they stop the cells producing new mature, healthy virus.

ANNOUNCER: It was only in the mid-1990s, with these many new drugs available, that doctors learned to combine three drugs at a time -- what's commonly known as HAART therapy.

This led to a dramatic change in patients' response to treatment.

Page 1 of 2 Next Page >>